• December 6, 2005

    J&J Medical Device Prevails In Trade Secret Appeal

    A Johnson & Johnson medical device prevailed in the U.S. Court of Appeals for the Sixth Circuit when the doctor that sued the company for trade secret violations failed to show proper similarity between his heart surgery device and J&J’s alleged copy.

  • December 2, 2005

    SEC In $25M Settlement Over Life Insurance Fraud

    The Securities and Exchange Commission has reached a $25 million settlement with a company it probed for allegedly defrauding thousands of terminally ill patients by manipulating their life insurance policies.

  • December 2, 2005

    SEC Eyes Merrill Lynch Over Pension Fund Conflict

    Merrill Lynch & Co. has been roped into the wide-ranging investigation of alleged conflicts of interest in the pension fund consulting industry, after receiving a subpoena from the Securities and Exchange Commission.

  • November 29, 2005

    Tiny Engine Maker Secures Funds For Suit Vs. Toyota

    Tiny electric engine maker Solomon Technologies Inc., whose patent infringement suit against auto giant Toyota stalled due to troubles financing the litigation, will proceed after the company secured funds to continue pressing its case.

  • November 22, 2005

    Gemstar Requests Second Probe Into $248M Fraud

    Dissatisfied with a sentence imposed by a California court on former CEO Henry Yuen, Gemstar TV-Guide has asked Florida prosecutors to investigate the $248 million accounting fraud allegedly orchestrated by Yuen during his tenure with the company.

  • November 21, 2005

    Brokerage To Pay $7M For Failure To Supervise Agent

    The Securities and Exchange Commission has entered a final judgment against a Florida financial services company and its president, who the Commission alleges failed to supervise an agent who defrauded investors of $15.5 million.

  • November 15, 2005

    Fresh Trouble At AIG As SEC Sends Wells Notices

    Unnamed employees at insurance giant American International Group Inc. (AIG) have received notices of an impending investigation from the Securities and Exchange Commission, according to the company’s chief executive officer Martin Sullivan.

  • November 14, 2005

    Sanofi-Aventis Must Allow News Site To Use Drug Name

    French pharmaceutical giant Sanofi-Aventis Group Inc. failed in federal court to stop a publisher from using the name of its yet-to-be-approved obesity drug in a news website’s address.

  • November 11, 2005

    Firm Profile: Lateral Hires Boost Duane Morris IP Group

    Eager to brandish its coast-to-coast credentials in intellectual property litigation, Philadelphia’s Duane Morris is quickly building a national platform by hiring laterals from competing firms across the U.S.

  • November 11, 2005

    Judge Bans Andrx, Ranbaxy Generic Versions Of Biaxin

    A federal judge has granted Abbott Laboratories Inc.’s request for a preliminary injunction against Ranbaxy Laboratories Ltd. and Andrx Corp. over its antibiotic Biaxin XL.

  • November 4, 2005

    Plea Bargain May Spell Trouble For Milberg Weiss

    A plea bargain by a former expert witness could whip up a storm for Milberg Weiss, amid allegations of kickbacks to lead plaintiffs by the firm that paved the way for the modern securities class-action industry.

  • November 1, 2005

    Novartis Purchase Of Chiron Puts Spotlight On Biologics

    Drug maker Novartis AG’s acquisition of Chiron Corp. will expand the Swiss company’s footprints in the U.S. biotech market even as its generics division braces for a battle to launch the first generic biotech drugs in the United States.

  • October 12, 2005

    Investors Sue Andrx Amid FDA Skirmish

    Investors took legal action against drug maker Andrx Corp. Tuesday, accusing the pharmaceutical company of violating federal securities laws and misrepresenting the approval status of new drug applications with the U.S. Food and Drug Administration.

  • October 19, 2005

    Biovail Files 2nd Suit To Protect Blood Pressure Drug

    After filing a new suit earlier this week, Biovail Laboratories now has two patent infringement lawsuits pending against Andrx Pharmaceuticals in the same court over the same drug.

  • October 6, 2005

    Alphapharm Concedes To Forest Labs In Antidepressant Battle

    Generic drug maker Alphapharm Pty Ltd. must steer clear of blockbuster antidepressant Lexapro for now as part its settlement agreement with Forest Laboratories Inc., ending litigation launched in May 2004.

  • October 4, 2005

    AmeriGroup Faces Class Action Suit Over Misleading Earnings Statements

    Managed healthcare company AmeriGroup Corporation is facing a class-action lawsuit from purchasers of its common stock for allegedly withholding damaging financial results during a five-month period to mislead investors.

  • September 29, 2005

    Florida Doctors Beat Johnson & Johnson In Patent Suit

    In a case that could end up costing Johnson & Johnson millions more, a federal jury has ruled that the health-care products giant knowingly infringed a patent held by two Florida doctors and ordered the company to pay the breast cancer specialists $2 million.

  • September 28, 2005

    AstraZeneca Faces Patent Challenge For Best-Selling Drug

    Israeli drug maker Teva Pharmaceutical Industries Ltd. is seeking to produce a generic version of the schizophrenia drug Seroquel, which garnered drug originator AstraZeneca $2 billion in worldwide sales last year.

  • September 23, 2005

    ANDA For Generic Epilepsy Drug Spurs Suit Against IVAX

    Belgian drugmaker UCB Societe Anonyme has sued IVAX Corporation in federal court, seeking protection of its popular epilepsy drug Keppra from generic competition before the expiration of its patent.

  • September 19, 2005

    Toyota’s Prius and Lexus Under Fire In European Patent Suit

    Toyota’s hybrid Prius has been drawing attention from consumers and patent holding companies alike, with yet another small transmission company asserting an obscure patent against the car maker.